3Tesfaye S, Stevens L K, Stephenson J M, et al.Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study[J].Diahetologia, 1996, 39(11): 1377-1384. 被引量：1
4Tesfaye S, Selvarajah D.Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy[J].Diahctes Metab Res Rev, 2012, 28(Suppl 1): 8-14. 被引量：1
5Kashyap A S, Anand K P, Kashyap S, et al.Peripheral nevropathy[J]. Lancet, 2004, 364(46): 1664-1665. 被引量：1
6Brownlee M.Biochemistry and molecular cell biology of climactic complications[J].Nature, 2001, 414(1): 813-820. 被引量：1
7Vincent A M, Callaghan B C, Smith A L, el al. Diabetic neuropathy: cellular mechanisms as therapeutic targets[J].Nat Rev Neurol, 2011, 7(10): 573-583. 被引量：1
